Literature DB >> 12887239

Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model.

Trupti A Gaonkar1, Lester A Sampath, Shanta M Modak.   

Abstract

OBJECTIVES: To evaluate the long-term efficacy of urinary Foley catheters (latex and silicone) impregnated with (1) chlorhexidine and silver sulfadiazine (CXS) and (2) chlorhexidine, silver sulfadiazine, and triclosan (CXST) in inhibiting extra-luminal bacterial adherence and to compare their efficacy with that of silver hydrogel latex (SH) and nitrofurazone-treated silicone (NF) catheters.
DESIGN: The antimicrobial spectrum of these catheters was evaluated using a zone of inhibition assay. A novel in vitro urinary tract model was developed to study the potential in vivo efficacy of antimicrobial catheters in preventing extraluminal bacterial colonization. The "meatus" was inoculated daily with Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Enterococcus faecalis, Pseudomonas aerginosa, and Candida albicans. The "bladder" portion of the model was cultured daily to determine bacterial growth.
RESULTS: Both CXS and CXST catheters had a broader antimicrobial spectrum than SH and NF catheters. In the in vitro model, CXST latex and silicone catheters exhibited significantly better efficacy (3 to 25days) against uropathogens, compared with CXS (1 to 14 days) and control (0 to 5 days) catheters (P = .01). CXST latex catheters exhibited significantly longer protection against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa, compared with SH catheters (P = .01). CXST silicone catheters resisted colonization with Staphylococcus aureus and Staphylococcus epidermidis for a significantly longer period (23 to 24 days) than did NF catheters (9 to 11 days) (P = .01).
CONCLUSION: Catheters impregnated with synergistic combinations of chlorhexidine, silver sulfadiazine, and triclosan exhibited broad-spectrum, long-term resistance against microbial colonization on their outer surfaces.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887239     DOI: 10.1086/502241

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  17 in total

1.  Effects of Formulation on Microbicide Potency and Mitigation of the Development of Bacterial Insusceptibility.

Authors:  Nicola L Cowley; Sarah Forbes; Alejandro Amézquita; Peter McClure; Gavin J Humphreys; Andrew J McBain
Journal:  Appl Environ Microbiol       Date:  2015-08-07       Impact factor: 4.792

Review 2.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

3.  Anti-Biofilm Effect of Octenidine and Polyhexanide on Uropathogenic Biofilm-Producing Bacteria.

Authors:  Maria Loose; Kurt G Naber; Larry Purcell; Manfred P Wirth; Florian M E Wagenlehner
Journal:  Urol Int       Date:  2021-01-05       Impact factor: 2.089

4.  epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox
Journal:  J Hosp Infect       Date:  2014-01       Impact factor: 3.926

5.  Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes.

Authors:  Namrata Raman; Myung-Ryul Lee; Sean P Palecek; David M Lynn
Journal:  J Control Release       Date:  2014-05-24       Impact factor: 9.776

Review 6.  Synthetic antibiofilm peptides.

Authors:  César de la Fuente-Núñez; Marlon Henrique Cardoso; Elizabete de Souza Cândido; Octavio Luiz Franco; Robert E W Hancock
Journal:  Biochim Biophys Acta       Date:  2015-12-23

7.  epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  R J Pratt; C M Pellowe; J A Wilson; H P Loveday; P J Harper; S R L J Jones; C McDougall; M H Wilcox
Journal:  J Hosp Infect       Date:  2007-02       Impact factor: 3.926

Review 8.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.

Authors:  Namrata Raman; Myung-Ryul Lee; Angélica de L Rodríguez López; Sean P Palecek; David M Lynn
Journal:  Acta Biomater       Date:  2016-07-12       Impact factor: 8.947

10.  On-demand release of Candida albicans biofilms from urinary catheters by mechanical surface deformation.

Authors:  Stacey A Maskarinec; Zehra Parlak; Qing Tu; Vrad Levering; Stefan Zauscher; Gabriel P López; Vance G Fowler; John R Perfect
Journal:  Biofouling       Date:  2018-06-13       Impact factor: 3.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.